Adams E K, Kreling D H, Gondek K
Emory University School of Public Health, Atlanta, GA 30329.
Health Care Financ Rev. 1994 Spring;15(3):25-42.
Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid payments to pharmacies. In this study, several data sources were used to develop 1991 estimates of average pharmacy ingredient and dispensing costs. A simulation was used to estimate the amounts States pay. Nationally, simulated payments averaged 96 percent of estimated costs overall but were lower for dispensing costs (79 percent) and higher for ingredient costs (102 percent).
尽管处方药似乎并非近期医疗补助计划支出激增的主要源头，但尽管采取了成本控制措施，其在医疗补助计划支出中的占比仍有所上升。作为对处方药政策普遍关注的一部分，国会要求对医疗补助计划向药房支付费用的充足性进行一项研究。在这项研究中，使用了多个数据源来编制1991年药房平均药品成分成本和配药成本的估计数。采用了一种模拟方法来估计各州的支付金额。在全国范围内，模拟支付平均占估计总成本的96%，但配药成本的支付比例较低（79%），药品成分成本的支付比例较高（102%）。
